This injection is an immunotherapy prescription medicine that belongs to the class of medications known as monoclonal antibodies. Therefore, patients specifically use durvalumab 500mg injection for NSCLC. It works by binding to the PD-L1 protein that helps your immune system to recognise and attack the cancer cells in the body. visit more - https://www.globanspharma.com/products/imfinzi-500mg-injection